(Q82860713)
Statements
A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients (English)
Johnson AG
Pearce GL
scientific article published on 16 March 2006
No description defined